Literature DB >> 19423977

Risk of neurological decompression sickness in the diver with a right-to-left shunt: literature review and meta-analysis.

Olivier Lairez1, Maxime Cournot, Vincent Minville, Jérôme Roncalli, Julien Austruy, Meyer Elbaz, Michel Galinier, Didier Carrié.   

Abstract

OBJECTIVE: Literature review and meta-analysis to review the evidence of relationship between the presence of right-to-left shunts (RLSs) and the occurrence of neurological decompression sickness (DCS) in divers. DATA SOURCES: MEDLINE, Google Scholar, and Health Technology Assessment databases. STUDY SELECTION: Five case-control studies in which the prevalence of a RLS in a group of divers with neurological DCS was compared with that of a group of divers with no history of DCS, 3 cross-transversal studies in which the prevalence of RLS was measured in divers with neurological DCS, and 4 cross-transversal studies in which the prevalence of RLS was measured in divers with no history of DCS were reviewed. DATA EXTRACTION: Only case-control studies were retained for meta-analysis. DATA SYNTHESIS: This meta-analysis gathers 5 studies and 654 divers. The combined odds ratio of neurological DCS in divers with RLS was 4.23 (3.05-5.87). The meta-analysis including only large RLS found a combined odds ratio of 6.49 (4.34-9.71).
CONCLUSIONS: Because of a low incidence of neurological DCS, increase in absolute risk of neurological DCS due to RLS is probably small. Thus, in recreational diving, the systematic screening of RLS seems unnecessary. In professional divers, because of a chronic exposition and unknown consequences of cerebral asymptomatic lesions, these results raise again the benefit of the transcranial Doppler in the screening and quantification of the RLS, independently of their location.

Entities:  

Mesh:

Year:  2009        PMID: 19423977     DOI: 10.1097/JSM.0b013e31819b0fa2

Source DB:  PubMed          Journal:  Clin J Sport Med        ISSN: 1050-642X            Impact factor:   3.638


  7 in total

1.  The effectiveness of risk mitigation interventions in divers with persistent (patent) foramen ovale.

Authors:  George Anderson; Douglas Ebersole; Derek Covington; Petar J Denoble
Journal:  Diving Hyperb Med       Date:  2019-06-30       Impact factor: 0.887

Review 2.  The management of patent foramen ovale in divers: where do we stand?

Authors:  Anastasios Apostolos; Maria Drakopoulou; George Trantalis; Αndreas Synetos; George Oikonomou; Theodoros Karapanayiotides; Costas Tsioufis; Konstantinos Toutouzas
Journal:  Ther Adv Neurol Disord       Date:  2022-07-09       Impact factor: 6.430

3.  Does persistent (patent) foramen ovale closure reduce the risk of recurrent decompression sickness in scuba divers?

Authors:  Björn Edvinsson; Ulf Thilén; Niels Erik Nielsen; Christina Christersson; Mikael Dellborg; Peter Eriksson; Joanna Hlebowicz
Journal:  Diving Hyperb Med       Date:  2021-03-31       Impact factor: 0.887

Review 4.  A review of diving practices and outcomes following the diagnosis of a persistent (patent) foramen ovale in compressed air divers with a documented episode of decompression sickness.

Authors:  Christopher W Scarff; John Lippmann; Andrew Fock
Journal:  Diving Hyperb Med       Date:  2020-12-20       Impact factor: 0.887

5.  Secundum atrial septal defect in adults: a practical review and recent developments.

Authors:  Joey M Kuijpers; Barbara J M Mulder; Berto J Bouma
Journal:  Neth Heart J       Date:  2015-04       Impact factor: 2.380

6.  Decompression illness with hypovolemic shock and neurological failure symptoms after two risky dives: a case report.

Authors:  Sebastian Klapa; Johannes Meyne; Wataru Kähler; Frauke Tillmans; Henning Werr; Andreas Binder; Andreas Koch
Journal:  Physiol Rep       Date:  2017-03

Review 7.  Patent Foramen Ovale-A Not So Innocuous Septal Atrial Defect in Adults.

Authors:  Veronica Romano; Carlo Maria Gallinoro; Rosita Mottola; Alessandro Serio; Franca Di Meglio; Clotilde Castaldo; Felice Sirico; Daria Nurzynska
Journal:  J Cardiovasc Dev Dis       Date:  2021-05-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.